MDSpire - Takeaway
From the Journals

UTICalc 3.0 Shows Promise for UTI Risk

Online risk tool may help guide urine testing decisions

Share

  • 1

    Study evaluated UTICalc's accuracy for predicting UTIs in febrile children.

  • 2

    2,561 patients aged 2-24 months were enrolled.

  • 3

    Clinical model included variables like fever duration and circumcision status.

  • 4

    Clinical and dipstick model had an AUROC of 95%.

  • 5

    Sensitivity and specificity varied between thresholds.

  • 6

    Decision analysis indicated both models' net benefits.

  • 7

    Limitations included missing test results and reliance on caregiver reports.

  • 8

    Experienced clinicians outperformed UTICalc in the study.

Original Source(s)

UTICalc 3.0 Shows Promise for UTI Risk

  • by Matthew Solan

  • March 27, 2026

Related Content

FDA Drops Age Limit for Neffy

Needle-free epinephrine expands access for younger children meeting weight criteria

FDA Approves Gene Therapy for Severe Pediatric LAD-I

Approval expands treatment option for a rare pediatric immunodeficiency

Meningococcal Abscess Detected by MRI

MRI identifies rare intracranial complication following normal computed tomography